{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:17:45Z","timestamp":1763741865537,"version":"3.45.0"},"reference-count":22,"publisher":"American Animal Hospital Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>An 8 yr old, male, mixed-breed dog was presented with a 2 mo history of progressive weakness, worsened in the last 2 days before examination. Neurological examination revealed ambulatory tetraparesis, ataxia, and proprioceptive deficits in all four limbs. Menace response was reduced in the right eye and discomfort was detected on neck manipulation.<\/jats:p>\n                  <jats:p>\u2003Hematologic abnormalities included marked monocytosis. Magnetic resonance imaging of the brain and cervical spinal cord revealed multifocal lesions with heterogeneous contrast enhancement. Cerebrospinal fluid analysis showed atypical monocytoid cells with similar cells to those observed in peripheral blood and in bone marrow preparations. The dog was diagnosed with chronic myelomonocytic leukemia. Prednisolone and toceranib were administered with improvement of the neurological signs. After 6 wk, the dog presented for worsening of neurological signs and with the onset of epileptic seizures. The results of flow cytometry were compatible with the possible transformation to acute myeloid leukemia. Although rare, myeloid leukemia may be included in differential diagnosis of patients with central nervous system signs, especially in dogs with relevant hematological abnormalities. In this case, cerebrospinal fluid examination played a key role identifying atypical cells.<\/jats:p>","DOI":"10.5326\/jaaha-ms-7442","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:05:37Z","timestamp":1763741137000},"page":"7-11","source":"Crossref","is-referenced-by-count":0,"title":["Chronic Myelomonocytic Leukemia with Central Nervous System Involvement in a Dog"],"prefix":"10.5326","volume":"61","author":[{"given":"Ilaria","family":"Tartari","sequence":"first","affiliation":[{"name":"From Veterinary Neurological Center \u201cLa Fenice,\u201d Selargius, Italy (I.T., F.T., A.G.);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Tocco","sequence":"additional","affiliation":[{"name":"From Veterinary Neurological Center \u201cLa Fenice,\u201d Selargius, Italy (I.T., F.T., A.G.);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Cancedda","sequence":"additional","affiliation":[{"name":"Veterinary Clinic \u201cCancedda,\u201d Carbonia, Italy (G.C.);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Angioni","sequence":"additional","affiliation":[{"name":"Veterinary Clinic \u201cBarone Rossi,\u201d Cagliari, Italy (V.A.); and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Podda","sequence":"additional","affiliation":[{"name":"Veterinary Clinic \u201cSan Francesco,\u201d Assemini, Italy (M.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Gallucci","sequence":"additional","affiliation":[{"name":"From Veterinary Neurological Center \u201cLa Fenice,\u201d Selargius, Italy (I.T., F.T., A.G.);"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3280","reference":[{"key":"i1547-3317-61-1-7-b1","series-title":"Leukemia\u00a0","first-page":"1703","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","unstructured":"Khoury\n              JD,\n            \n            \n              Solary\n              E,\n            \n            \n              Abla\n              O,\n            \n            \n          \n          The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms.\u00a0Leukemia\u00a02022;36:1703\u201319."},{"key":"i1547-3317-61-1-7-b2","series-title":"Nat Commun\u00a0","first-page":"2901","article-title":"RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis","volume":"12","author":"Carr","year":"2021","unstructured":"Carr\n              RM,\n            \n            \n              Vorobyev\n              D,\n            \n            \n              Lasho\n              T,\n            \n            \n          \n          RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis. Nat Commun\u00a02021;12:2901."},{"key":"i1547-3317-61-1-7-b3","series-title":"Blood Adv","first-page":"1807","article-title":"Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories","volume":"2","author":"Loghavi","year":"2018","unstructured":"Loghavi\n              S,\n            \n            \n              Sui\n              D,\n            \n            \n              Wei\n              P,\n            \n            \n          \n          Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories. Blood Adv2018;2:1807\u201316."},{"key":"i1547-3317-61-1-7-b4","series-title":"Am J Hematol\u00a0","first-page":"352","article-title":"Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Patnaik","year":"2022","unstructured":"Patnaik\n              MM,\n            \n            \n              Tefferi\n              A.\n            \n          \n          Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management. Am J Hematol\u00a02022;97:352\u201372."},{"key":"i1547-3317-61-1-7-b5","series-title":"Withrow & MacEwen\u2019s Small Animal Clinical Oncology.","first-page":"730","author":"Vail","year":"2020","unstructured":"Vail\n              DM,\n            \n            \n              Young\n              KM.\n            \n          \n          Hematopoietic tumors; section C: canine acute myeloid leukemia, myeloproliferative neoplasms, and myelodysplasia. In: VailDM,ThammDH,LiptakJM, eds. Withrow & MacEwen\u2019s Small Animal Clinical Oncology.6th ed. Elsevier; 2020:730\u20139."},{"key":"i1547-3317-61-1-7-b6","series-title":"Veterinary Comparative Hematopathology.","first-page":"461","author":"Valli","year":"2007","unstructured":"Valli\n              VE.\n            \n          \n          Myeloproliferative\/myelodysplastic disease. In: ValliEV, ed. Veterinary Comparative Hematopathology.1st ed. Blackwell Publishing; 2007:461\u201371."},{"key":"i1547-3317-61-1-7-b7","series-title":"J Vet Med Sci\u00a0","first-page":"665","article-title":"A dog with myelodysplastic syndrome: chronic myelomonocytic leukemia","volume":"69","author":"Hiraoka","year":"2007","unstructured":"Hiraoka\n              H,\n            \n            \n              Hisasue\n              M,\n            \n            \n              Nagashima\n              N,\n            \n            \n          \n          A dog with myelodysplastic syndrome: chronic myelomonocytic leukemia. J Vet Med Sci\u00a02007;69:665\u20138."},{"key":"i1547-3317-61-1-7-b8","series-title":"Vet Clin Pathol","first-page":"314","article-title":"Molecular characterization of canine BCR\u2010ABL\u2013positive chronic myelomonocytic leukemia before and after chemotherapy","volume":"42","author":"Culver","year":"2013","unstructured":"Culver\n              S,\n            \n            \n              Ito\n              D,\n            \n            \n              Borst\n              L,\n            \n            \n          \n          Molecular characterization of canine BCR\u2010ABL\u2013positive chronic myelomonocytic leukemia before and after chemotherapy.\u00a0Vet Clin Pathol2013;42:314\u201322."},{"key":"i1547-3317-61-1-7-b9","series-title":"J Vet Med Sci\u00a0","first-page":"195","article-title":"Chronic myelomonocytic leukemia in a cat","volume":"62","author":"Shimoda","year":"2000","unstructured":"Shimoda\n              T,\n            \n            \n              Shiranaga\n              N,\n            \n            \n              Mashita\n              T,\n            \n            \n          \n          Chronic myelomonocytic leukemia in a cat. J Vet Med Sci\u00a02000;62:195\u20137."},{"key":"i1547-3317-61-1-7-b10","series-title":"Cowell and Tyler\u2019s Diagnostic Cytology and Hematology of the Dog and Cat.","first-page":"210","author":"Levine","year":"2020","unstructured":"Levine\n              GJ,\n            \n            \n              Cook\n              JR.\n            \n          \n          Cerebrospinal fluid and central nervous system cytology. In: ValencianoAC,CowellRL, eds. Cowell and Tyler\u2019s Diagnostic Cytology and Hematology of the Dog and Cat.5th ed. Elsevier; 2020:210\u201328."},{"key":"i1547-3317-61-1-7-b11","series-title":"Leuk Lymphoma","first-page":"2267","article-title":"Chronic myelomonocytic leukemia with central nervous system involvement","volume":"59","author":"Hannon","year":"2018","unstructured":"Hannon\n              M,\n            \n            \n              Wilde\n              L,\n            \n            \n              Nwaoduah,\n              N,\n            \n            \n          \n          Chronic myelomonocytic leukemia with central nervous system involvement.\u00a0Leuk Lymphoma2018;59:2267\u20138."},{"key":"i1547-3317-61-1-7-b12","series-title":"J Neurol\u00a0","first-page":"993","article-title":"Meningeal involvement of chronic myelomonocytic leukemia","volume":"250","author":"Aoyama","year":"2003","unstructured":"Aoyama\n              K,\n            \n            \n              Ishikura\n              H,\n            \n            \n              Tsumura\n              H,\n            \n            \n          \n          Meningeal involvement of chronic myelomonocytic leukemia.\u00a0J Neurol\u00a02003;250:993\u20134."},{"key":"i1547-3317-61-1-7-b13","series-title":"J Med Case Rep","first-page":"368","article-title":"Cerebral localization of chronic myelomonocytic leukemia: a case report.\u00a0","volume":"15","author":"Ham\u00e9on","year":"2021","unstructured":"Ham\u00e9on\n              C,\n            \n            \n              Rousselot\n              C,\n            \n            \n              Arbion\n              F,\n            \n            \n          \n          Cerebral localization of chronic myelomonocytic leukemia: a case report.\u00a0\n          \n            J Med Case Rep\n          \n          2021;15:368."},{"key":"i1547-3317-61-1-7-b14","series-title":"eJHaem","first-page":"844","article-title":"Cerebral localization of chronic myelomonocytic leukemia and improvement with high\u2010dose cytarabine: A case report","volume":"4","author":"Ham\u00e9on","year":"2023","unstructured":"Ham\u00e9on\n              C,\n            \n            \n              Machet\n              A,\n            \n            \n              Drieu La Rochelle\n              L,\n            \n            \n          \n          Cerebral localization of chronic myelomonocytic leukemia and improvement with high\u2010dose cytarabine: A case report.\u00a0eJHaem2023;4:844\u20137."},{"key":"i1547-3317-61-1-7-b15","series-title":"J Leuk","first-page":"147","article-title":"Meningeal infiltration of chronic myelomonocytic leukemia","volume":"2","author":"Rogulj","year":"2014","unstructured":"Rogulj\n              IM,\n            \n            \n              Kolonic\n              SO,\n            \n            \n              Kristo\n              DR,\n            \n            \n          \n          Meningeal infiltration of chronic myelomonocytic leukemia.\u00a0J Leuk2014;2:147."},{"key":"i1547-3317-61-1-7-b16","series-title":"Haematologica","first-page":"675","article-title":"New methodological approaches for immunophenotyping acute leukemias","volume":"86","author":"Basso","year":"2001","unstructured":"Basso\n              G,\n            \n            \n              Buldini\n              B,\n            \n            \n              De Zen\n              L,\n            \n            \n          \n          New methodological approaches for immunophenotyping acute leukemias. Haematologica2001;86:675\u201392."},{"key":"i1547-3317-61-1-7-b17","series-title":"Vet Clin Pathol","first-page":"2","article-title":"Hematologic abnormalities and flow cytometric immunophenotyping results in dogs with hematopoietic neoplasia: 210 cases (2002\u20132006)","volume":"38","author":"Tasca","year":"2009","unstructured":"Tasca\n              S,\n            \n            \n              Carli\n              E,\n            \n            \n              Caldin\n              M,\n            \n            \n          \n          Hematologic abnormalities and flow cytometric immunophenotyping results in dogs with hematopoietic neoplasia: 210 cases (2002\u20132006).\u00a0Vet Clin Pathol2009;38:2\u201312."},{"key":"i1547-3317-61-1-7-b18","series-title":"Anticancer Drugs","first-page":"1098","article-title":"Partial cytogenetic response with toceranib and prednisone treatment in a young dog with chronic monocytic leukemia","volume":"24","author":"P\u00e9rez","year":"2013","unstructured":"P\u00e9rez\n              ML,\n            \n            \n              Culver\n              S,\n            \n            \n              Owen\n              JL,\n            \n            \n          \n          Partial cytogenetic response with toceranib and prednisone treatment in a young dog with chronic monocytic leukemia.\u00a0Anticancer Drugs2013;24:1098\u2013103."},{"key":"i1547-3317-61-1-7-b19","series-title":"Blood","first-page":"2375","article-title":"The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype","volume":"88","author":"Melo","year":"1996","unstructured":"Melo\n              JV.\n            \n          \n          The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood1996;88:2375\u201384."},{"key":"i1547-3317-61-1-7-b20","series-title":"J Vet Pharmacol Ther","first-page":"162","article-title":"Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors","volume":"33","author":"Yancey","year":"2010","unstructured":"Yancey\n              MF,\n            \n            \n              Merritt\n              DA,\n            \n            \n              Lesman\n              SP,\n            \n            \n          \n          Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors. J Vet Pharmacol Ther2010;33:162\u201371."},{"key":"i1547-3317-61-1-7-b21","series-title":"Blood Res","first-page":"5","article-title":"Diagnosis and treatment of chronic myelomonocytic leukemia","volume":"56","author":"Kwon","year":"2021","unstructured":"Kwon\n              J.\n            \n          \n          Diagnosis and treatment of chronic myelomonocytic leukemia.\u00a0Blood Res2021;56:5\u201316."},{"key":"i1547-3317-61-1-7-b22","series-title":"Blood","first-page":"840","article-title":"Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients","volume":"99","author":"Onida","year":"2002","unstructured":"Onida\n              F,\n            \n            \n              Kantarjian\n              HM,\n            \n            \n              Smith\n              TL,\n            \n            \n          \n          Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.\u00a0Blood2002;99:840\u20139."}],"container-title":["Journal of the American Animal Hospital Association"],"original-title":[],"link":[{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/61\/1\/article-p7.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/61\/1\/article-p7.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/61\/1\/article-p7.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:05:57Z","timestamp":1763741157000},"score":1,"resource":{"primary":{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/61\/1\/article-p7.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":22,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.5326\/jaaha-ms-7442","relation":{},"ISSN":["1547-3317","0587-2871"],"issn-type":[{"value":"1547-3317","type":"electronic"},{"value":"0587-2871","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}